NLRP3 and non-small cell lung carcinoma: In addition to the NLRP3 inflammasome, the AIM2 inflammasome was reported to present high expression levels in non-small cell lung cancer cells (NSCLCs) and to exert tumor-promoting ability both in vivo and in vitro (66, 67).